Zai Lab Statistics
Total Valuation
Zai Lab has a market cap or net worth of $2.40 billion. The enterprise value is $1.91 billion.
Important Dates
The last earnings date was Thursday, November 6, 2025, before market open.
| Earnings Date | Nov 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Zai Lab has 110.59 million shares outstanding. The number of shares has increased by 10.28% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 110.59M |
| Shares Change (YoY) | +10.28% |
| Shares Change (QoQ) | +0.93% |
| Owned by Insiders (%) | 1.72% |
| Owned by Institutions (%) | 65.66% |
| Float | 97.61M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.29 |
| Forward PS | 12.43 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.42 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 4.31 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.87, with a Debt / Equity ratio of 0.29.
| Current Ratio | 2.87 |
| Quick Ratio | 2.29 |
| Debt / Equity | 0.29 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -47.96 |
Financial Efficiency
Return on equity (ROE) is -28.97% and return on invested capital (ROIC) is -16.07%.
| Return on Equity (ROE) | -28.97% |
| Return on Assets (ROA) | -13.29% |
| Return on Invested Capital (ROIC) | -16.07% |
| Return on Capital Employed (ROCE) | -28.52% |
| Revenue Per Employee | $236,292 |
| Profits Per Employee | -$110,654 |
| Employee Count | 1,869 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 7.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -24.97% in the last 52 weeks. The beta is 0.85, so Zai Lab's price volatility has been lower than the market average.
| Beta (5Y) | 0.85 |
| 52-Week Price Change | -24.97% |
| 50-Day Moving Average | 29.39 |
| 200-Day Moving Average | 32.59 |
| Relative Strength Index (RSI) | 23.25 |
| Average Volume (20 Days) | 959,791 |
Short Selling Information
| Short Interest | 5.02M |
| Short Previous Month | 4.81M |
| Short % of Shares Out | 5.15% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 7.38 |
Income Statement
In the last 12 months, Zai Lab had revenue of $441.63 million and -$206.81 million in losses. Loss per share was -$1.92.
| Revenue | 441.63M |
| Gross Profit | 40.56M |
| Operating Income | -227.92M |
| Pretax Income | -206.81M |
| Net Income | -206.81M |
| EBITDA | -213.79M |
| EBIT | -227.92M |
| Loss Per Share | -$1.92 |
Full Income StatementBalance Sheet
The company has $717.16 million in cash and $219.36 million in debt, giving a net cash position of $497.79 million or $4.50 per share.
| Cash & Cash Equivalents | 717.16M |
| Total Debt | 219.36M |
| Net Cash | 497.79M |
| Net Cash Per Share | $4.50 |
| Equity (Book Value) | 759.95M |
| Book Value Per Share | 6.87 |
| Working Capital | 673.18M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$180.54 million and capital expenditures -$10.02 million, giving a free cash flow of -$190.56 million.
| Operating Cash Flow | -180.54M |
| Capital Expenditures | -10.02M |
| Free Cash Flow | -190.56M |
| FCF Per Share | -$1.72 |
Full Cash Flow StatementMargins
Gross margin is 9.18%, with operating and profit margins of -51.61% and -46.83%.
| Gross Margin | 9.18% |
| Operating Margin | -51.61% |
| Pretax Margin | -46.83% |
| Profit Margin | -46.83% |
| EBITDA Margin | -48.41% |
| EBIT Margin | -51.61% |
| FCF Margin | n/a |
Dividends & Yields
Zai Lab does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.28% |
| Shareholder Yield | -10.28% |
| Earnings Yield | -8.61% |
| FCF Yield | -7.93% |
Dividend DetailsAnalyst Forecast
The average price target for Zai Lab is $57.22, which is 163.32% higher than the current price. The consensus rating is "Buy".
| Price Target | $57.22 |
| Price Target Difference | 163.32% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
| Revenue Growth Forecast (5Y) | 39.53% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Zai Lab has an Altman Z-Score of 2.43 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.43 |
| Piotroski F-Score | 3 |
